XIST and Alzheimer disease: In these cells, XIST was found to enhance Aβ25-35-induced toxicity, oxidative stress, and apoptosis by binding and downregulating the expression of neuroprotective miR-132, which has already been reported to be downregulated in human AD brains and involved in AD pathogenesis (Table S1) [166].